| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.71 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |